FINANCIAL SUMMARY FOR THE THREE MONTHS ENDED
- Revenues from continuing operations of
$0.5 million , an increase of 24.4% compared to the same period in the prior year. - Operating expenses from continuing operations of
$1.8 million , a decrease of 13.2% compared to the same period in the prior year. - Loss from continuing operations of
$1.1 million , or$0.07 per share, compared to an income of$13.9 million , or$0.83 per share, for the same period in the prior year, which included the net gain from the patent assignment of$15.5 million . - Cash used by operations of
$1.6 million , compared to$1.5 million for the same period in the prior year. - Cash and accounts receivable of
$20.2 million as ofSeptember 30, 2026 compared to$25.8 million as ofDecember 31, 2025 .
FINANCIAL SUMMARY FOR THE NINE MONTHS ENDED
- Revenues from continuing operations of
$1.6 million , an increase of 5.4% compared to the same period in the prior year. - Operating expenses from continuing operations of
$7.3 million , an increase of 0.2% compared to the same period in the prior year. - Loss from continuing operations of
$5.1 million , or$0.31 per share, compared to an income of$10.2 million , or$0.60 per share, for the same period in the prior year, which included the net gain from the patent assignment of$15.5 million . - Cash used by operations of
$5.6 million , compared to$4.6 million for the same period in the prior year.
THE CEO'S COMMENTS
"During the third quarter, we continued the transformation of
"Alongside this growth, we maintained cost discipline, with operating expenses lower than in the same quarter last year."
"Looking at the first nine months, revenue and licensing income grew, including 13% growth in licensing, while operating expenses remained broadly stable. MultiSensing licensing revenue nearly quadrupled in January–September 2026 compared with the same period in 2025. However, our revenue base is not yet sufficient to achieve profitability, and operations continued to reduce our cash balance during the quarter. Converting commercial opportunities into revenue while keeping costs under control remains essential."
"The substantial year-over-year difference in earnings primarily reflects the one-time gain from patent assignment recognized in the third quarter of 2025. That contribution was not repeated this year, and the comparison should not be interpreted as a corresponding deterioration in the underlying business."
"Our priorities remain clear: deliver on existing customer programs, convert evaluations and partner engagements into commercial agreements, and build our licensing business with financial discipline. Our liquidity provides a foundation to pursue these priorities, and our focus remains on turning technology and commercial opportunities into sustainable revenue growth and long-term shareholder value," concluded
FINANCIAL OVERVIEW FOR THE QUARTER ENDED
Revenues from continuing operations for the three months ended
Operating expenses from continuing operations for the three months ended
Loss from continuing operations for the three months ended
Cash used by operations was
Cash and accounts receivable totaled
For more information, please contact:
President and Chief Executive Officer
E-mail: daniel.alexus@neonode.com
Phone: +46 767 60 29 90
Chief Financial Officer
Fredrik Nihlén
E-mail: fredrik.nihlen@neonode.com
Phone: +46 703 97 21 09
This information was brought to you by Cision http://news.cision.com
The following files are available for download:
| | |
| Neonode Reports Quarter Ended |
View original content:https://www.prnewswire.com/news-releases/neonode-reports-quarter-ended-september-30-2026-financial-results-302937981.html
SOURCE